Lara Clemens

Lara Clemens

Scientist II
DILIsym Services

Lara Clemens, Ph.D.
Scientist II
DILIsym Services Division

About Lara
Dr. Clemens’s current research is focused on developing the new Quantitative Systems Pharmacology/Toxicology modeling software, RENAsym, and advancing the established platform, DILIsym. She also works with the immunology team to develop mechanistic models of how the innate and adaptive immune systems play a role in drug-induced kidney and liver injury.

Prior to DILIsym Services, Dr. Clemens graduated with a Ph.D. in Mathematical, Computational, and Systems Biology from University of California, Irvine. In her graduate work, she developed computational models to assess how characteristics of intrinsically disordered proteins influence their binding kinetics, with a focus on the disordered signaling subunits of immunoreceptors. She received a Bachelor of Science in Mathematics and Biochemistry from St. Lawrence University.

Latest Research by Lara Clemens